New Initiative to Educate Sleep Disorder Community on Cardiovascular Risks

With expanded financial support from Jazz Pharmaceuticals plc, the American Heart Association is launching an initiative to provide the sleep disorder community with an understanding of the cardiovascular risks associated with sleep disorders.  Through the initiative, the American Heart Association aims to help people with sleep disorders determine when professional help may be appropriate and…

Read More

Daytime Sleep Apnea Therapy eXciteOSA Surpasses 10,000 Patient Milestone

eXciteOSA, the first FDA-authorized daytime therapy for sleep-disordered breathing, has treated over 10,000 patients since its commercial launch in 2021 by Signifier Medical.  “This is a proud moment knowing that our therapy has made a positive impact on the lives of so many patients,” says Akhil Tripathi, Signifier Medical co-founder and CEO, in a press…

Read More